These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 31539133)
1. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185. Liu L; Zhu Y; Liu AM; Feng Y; Chen Y Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7457-7468. PubMed ID: 31539133 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA FAM201A involves in radioresistance of non-small-cell lung cancer by enhancing EGFR expression via miR-370. Liu AM; Zhu Y; Huang ZW; Lei L; Fu SZ; Chen Y Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5802-5814. PubMed ID: 31298332 [TBL] [Abstract][Full Text] [Related]
3. LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis. Zhang H; Zhao B; Wang X; Zhang F; Yu W Life Sci; 2019 Jul; 228():135-144. PubMed ID: 31047896 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LINC00511/miR-150/MMP13 axis promotes breast cancer proliferation, migration and invasion. Shi G; Cheng Y; Zhang Y; Guo R; Li S; Hong X Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):165957. PubMed ID: 33031905 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236 [TBL] [Abstract][Full Text] [Related]
6. Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom. Guo W; Yu Q; Zhang M; Li F; Liu Y; Jiang W; Jiang H; Li H Aging (Albany NY); 2019 Aug; 11(15):5351-5367. PubMed ID: 31386627 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LINC00511 induced by SP1 accelerates the glioma progression through targeting miR-124-3p/CCND2 axis. Li C; Liu H; Yang J; Yang J; Yang L; Wang Y; Yan Z; Sun Y; Sun X; Jiao B J Cell Mol Med; 2019 Jun; 23(6):4386-4394. PubMed ID: 30973678 [TBL] [Abstract][Full Text] [Related]
8. Increased long noncoding RNA LINC00511 is correlated with poor prognosis and contributes to cell proliferation and metastasis by modulating miR-424 in hepatocellular carcinoma. Wang RP; Jiang J; Jiang T; Wang Y; Chen LX Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3291-3301. PubMed ID: 31081082 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer. Huang HG; Tang XL; Huang XS; Zhou L; Hao YG; Zheng YF Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4232-4245. PubMed ID: 32373959 [TBL] [Abstract][Full Text] [Related]
10. LINC00511 as a ceRNA promotes cell malignant behaviors and correlates with prognosis of hepatocellular carcinoma patients by modulating miR-195/EYA1 axis. Hu WY; Wei HY; Li KM; Wang RB; Xu XQ; Feng R Biomed Pharmacother; 2020 Jan; 121():109642. PubMed ID: 31731191 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LINC00511 regulates the proliferation, apoptosis, invasion and autophagy of trophoblast cells to mediate pre-eclampsia progression through modulating the miR-31-5p/homeobox protein A7 axis. Dong X; Zhang Y; Chen X; Xue M J Obstet Gynaecol Res; 2020 Aug; 46(8):1298-1309. PubMed ID: 32558037 [TBL] [Abstract][Full Text] [Related]
12. Promotion of cell autophagy and apoptosis in cervical cancer by inhibition of long noncoding RNA LINC00511 via transcription factor RXRA-regulated PLD1. Shi Y; Liu M; Huang Y; Zhang J; Yin L J Cell Physiol; 2020 Oct; 235(10):6592-6604. PubMed ID: 32067228 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells. Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LINC00511 regulates the expression of microRNA-625-5p and activates signal transducers and activators of transcription 3 (STAT3) to accelerate the progression of gastric cancer. Cui N; Sun Q; Liu H; Li L; Guo X; Shi Y; Jing C; Qin C; Zhao Y Bioengineered; 2021 Dec; 12(1):2915-2927. PubMed ID: 34224294 [TBL] [Abstract][Full Text] [Related]
15. LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR-449b-5p. Zhang S; Wang B; Xiao H; Dong J; Li Y; Zhu C; Jin Y; Li H; Cui M; Fan S Thorac Cancer; 2020 Jul; 11(7):1801-1816. PubMed ID: 32374522 [TBL] [Abstract][Full Text] [Related]
16. Long intergenic non-coding RNA 511 correlates with improved prognosis, and hinders osteosarcoma progression both in vitro and in vivo. Qiao S; Qi K; Liu C; Xu C; Ma J; Xu X; Li C; Wang Z J Clin Lab Anal; 2020 May; 34(5):e23164. PubMed ID: 31893577 [TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate reverses gastric cancer by regulating the long noncoding RNA LINC00511/miR-29b/KDM2A axis. Zhao Y; Chen X; Jiang J; Wan X; Wang Y; Xu P Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165856. PubMed ID: 32512188 [TBL] [Abstract][Full Text] [Related]
18. HIF-1α induced lncRNA LINC00511 accelerates the colorectal cancer proliferation through positive feedback loop. Sun S; Xia C; Xu Y Biomed Pharmacother; 2020 May; 125():110014. PubMed ID: 32092829 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA HOTAIR knockdown enhances radiosensitivity through regulating microRNA-93/ATG12 axis in colorectal cancer. Liu Y; Chen X; Chen X; Liu J; Gu H; Fan R; Ge H Cell Death Dis; 2020 Mar; 11(3):175. PubMed ID: 32144238 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of LINC00511 enhances radiosensitivity of lung adenocarcinoma via regulating miR-497-5p/SMAD3. Li C; Fu Y; He Y; Huang N; Yue J; Miao Y; Lv J; Xiao Y; Deng R; Zhang C; Huang M Cancer Biol Ther; 2023 Dec; 24(1):2165896. PubMed ID: 36861928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]